Connect with us

Cannabis News

Congressional Leaders Drop Attempt To Block Marijuana Rescheduling, While Preserving State Medical Cannabis Protections

Published

on

Bipartisan House and Senate leaders have rejected a provision It would have prevented the Justice Department from rescheduling marijuana– Maintaining a long-standing rider while protecting state cannabis programs from federal interference.

While a GOP-controlled House committee advanced a version of Commerce, Justice, Science and Related Agencies (CJS) legislation this summer that would have prevented the DOJ from rescheduling cannabis, the new bicameral agreement introduced Monday omits that language.

The move by President Donald Trump to Attorney General Pam Bondi from Schedule I to III of the Marijuana Controlled Substances Act (CSA).

Here is the language of the provision advanced by the House Appropriations Committee, but left out of the final agreement:

“SEC. 607. Funds made available by this Act or otherwise made available may not be used to reschedule marijuana (as that term is defined in section 102 of the Controlled Substances Act (21 USC 802)) or to remove marijuana from the schedules established by section (802) of the Controlled Substances Act.”

GOP senators have it individually tried to block the administration from rescheduling cannabis As part of a stand-alone bill introduced in 2023, but that proposal was not heard or voted on.

Meanwhile, on Monday, the Drug Enforcement Administration (DEA) said Marijuana redistricting appeals process ‘remains pending’ Despite Trump’s executive order.

The newly introduced bicameral CJS bill, which is combining legislation to fund parts of the government covering the interior, environment and energy and water development, also includes a pilot that has been renewed annually since 2014 to block the Justice Department from using its funds to enact state medical marijuana laws.

However, for reasons that are unclear, the rider listing every state that would be protected omits Nebraska.

Here is the text of that provision:

“SEC. 531. None of the funds made available to the Department of Justice under this Act shall be used in Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, New Jersey, Massachusetts, Michigan, Minnesota, New Hampshire, New Jersey, Louisiana, Maine, Maryland, Arizona, Arkansas, California, Colorado, Connecticut, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Missouri, New Hampshire. Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or the Commonwealth of the Northern Mariana Islands, the United States Virgin Islands, or Puerto Rico, to authorize their use, distribution, or establishment of their own laws.”

Missing from the final version is an addition to that rider that the House had previously included, which would have allowed enhanced penalties for sales near schools and parks.

That provision specifically specified that the Justice Department could still enforce a section of the US Code that requires increased penalties for distributing cannabis within 1,000 feet of an elementary school, vocational school, university, playground or public housing.

However, a joint statement explaining the new spending package also states that Congress “directs proper enforcement of the Federal Drug-Free School Zones Act (2 1 USC 860) to ensure that areas where young children are present, including schools and playgrounds, remain drug-free.”

That appears to be related to a Senate committee report released earlier this year that found the medical marijuana protection pilot “does not expressly prevent” U.S. attorneys from enforcing a federal statute that prohibits the sale or manufacture of controlled substances in “areas where young children are present, schools and playgrounds.”

The new bill also maintains protections for state industrial hemp research programs under the 2014 Farm Bill:

“SEC. 530. None of the funds made available by this Act shall be used by the Department of Justice or the Drug Enforcement Administration in violation of Section 7606 (‘Legitimacy of Industrial Hemp Research’) of the Agriculture Act of 2014 (Public Law 113-79).

“President Trump laid an important foundation when he signed the three appropriations bills into law in November, and we’re carrying that momentum into the new year,” House Appropriations Committee Chairman Tom Cole (R-OK). he said in a press release. “This bipartisan, bicameral package reflects continued progress toward responsibly completing FY26 funding.”

Senate Appropriations Committee Chairwoman Susan Collins (R-ME) he said The overall agreement is “a fiscally responsible package that cuts spending, provides essential federal investments that will improve our nation’s water infrastructure, improve our nation’s energy and national security, and advance the scientific research needed to keep America competitive.”

Advocates may welcome the exclusion of the reconsideration provision and the inclusion of medical marijuana protections in the CJS bill, but many cannabis advocates protested Trump’s signing of a separate credit measure in November. It includes provisions to ban most consumable hemp products.

However, when the president ordered marijuana reregulation last month, he also directed Congress to review that policy and ensure that people continue to have access to full-spectrum CBD products. A federal agency will also move to cover these products for certain Medicare and Medicaid patients.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

Building Nevada’s most vertically integrated cannabis operation

Published

on

By

Nevada is one of the most competitive retail cannabis markets in the United States, and Deep Roots Harvest has been betting for years that the way to win is to control everything. 11 cultivation, processing, manufacturing, extraction and retail locations all under one roof, or pretty close to it. Chris O’Ferrell, Deep Roots Harvest’s Chief Cultivator, runs the growing side of that operation in two facilities totaling 30,000 square feet, pushing 500 pounds of harvested cannabis per week and 2,000 pounds of biomass per month.

“The Source and Deep Roots harvest retail team sells 75 kilos of cannabis daily, 500 kilos weekly, over a third of which is in-house to support the High Heads, Neon Moon and CAMP brands. We cultivate, extract, process, manufacture and work the retail locations,” says Chris. “We have one of the largest market shares in Nevada in terms of retail volume and gross sales.”

That volume is produced by 60 full-time employees at the two sites, and the crop program behind it is, by any reasonable measure, built for efficiency and quality. “Many of the genetics in our library consistently exceed 100 grams per square foot, which directly helps reduce our overall cost per gram,” explains Chris. “We operate with a consumer-first approach, focusing on cost consciousness while providing tasty and competitive offerings. We operate below 70 cents per gram, a benchmark that reflects careful cost management. Getting there and staying there has required compressing costs at all input levels while continuing to invest in technology that moves the needle on quality, cost efficiency and performance.”

© Deep Roots Harvest Chris O’Ferrell, Chief Cultivator at Deep Roots Harvest

Genetics as intended by the producer
The transition of light is a clear example of this, as is the case with cannabis. In the beginning, the company used your classic HPS lights. As LED technology advanced, Deep Roots made the switch. However, it wasn’t just about improving energy efficiency. Chris and the team understood that the more precisely the crop was targeted, the better the final product would be. Energy savings don’t necessarily show up on retail shelves, but crop control does, in the form of flowers that express their genetics the way the grower intended.

To achieve this level of control, the spectrum became a critical tool. “We start with the spring setting, using the blue light to regulate the spacing of the interiors and control the spacing,” he explains. “As the plants progress, we move to the summer spectrum until the end of week eight, switching to a broader spectrum light with balanced wavelengths. This increases the red light, along with other parts of the spectrum to more closely replicate sunlight. We also increase the light intensity during the flowering phase to improve the plant’s photosynthetic performance, accumulation and photosynthetic activity. The parameters support the initiation of flowering, accelerate maturation and allow the plant to reach its potential they allow him to fully express his genetics.”

Nothing is left to chance
At canopy level, plants from the two largest facilities are housed in two-gallon coco pots, chosen to accommodate longer growing periods and larger plant structures. The second facility operates stone wool. Both use substrate sensors in connection with fertigation control, and track performance at different growth stages. Dissolved oxygen is injected into the root zone to increase availability, and a chlorine injection system keeps the lines clear of pathogens with a relatively inexpensive cleanup compared to conventional cleaning programs. “A chlorine injection system is relatively inexpensive to implement, replacing approximately $40,000 in other cleaning and disinfection products annually,” says Chris. “It’s all about being ahead of the curve.”

Pest management is entirely biological, implemented in conjunction with mechanical and cultural controls. “We haven’t had any pest problems,” says Chris. “This was also a decision based on reducing inputs while maintaining, if not improving, the quality of the product.”

Genetics is the backbone of cannabis operations and the gas that drives the company’s engine. They receive the same systematic treatment as all other parts of the operation. A steering committee reviews the portfolio quarterly, withdrawing underperforming cultivars and acquiring replacements based on market data from multiple markets, cross-referenced with gaps in the current menu. The criteria are repeatable agronomic performance, yield, potency, distinctive flavor profile and the ability to wash well for extraction, ensuring strong yields for both rosin and resin production. “All genetics need to adapt to the program,” says Chris. “Unique production, potency and flavor expression that fills the void of what we don’t have on the menu. It’s about finding a commercial cultivar that works well and fits the existing infrastructure. All the cultivars we grow now have a similar and predictable growth structure. The difference is the color, the smell, the experience. They are very close agronomically.”

For more information:
Harvest deep roots
deeprootsharvest.com

Continue Reading

Cannabis News

Marijuana Reform Group Polls Consumers About Freedoms Where They Live Ahead Of 4/20

Published

on

By

Ahead of the unofficial cannabis holiday on 4/20, a leading marijuana reform group is asking consumers to take a poll about the freedoms they experience (or lack thereof) where they live.

The new 2026 Cannabis Freedom Survey from the National Organization for Reform of Marijuana Laws (NORML) includes the questions: “Where you live, how free are adults to legally possess and access cannabis?” and “Where you live, how concerned are you about the legal consequences for cannabis users?”

The survey “is designed to capture the real-time sentiment of cannabis consumers in the United States and abroad to see how individuals experience the politics of cannabis in their daily lives,” NORML said.

The the questioning It also includes a question asking people to choose “the most important step that would increase the freedom of cannabis where you live.”

Options include ending marijuana arrests, legalizing adult marijuana, allowing adults to grow their own cannabis, allowing the sale of legal cannabis, making legal cannabis cheaper, clearing records and resolving past convictions, changing federal cannabis laws and protecting consumer rights (parental, workplace, housing, health).

In addition, it asks whether respondents at the national level fully respect marijuana policy for consumer freedom, whether it is moving in the right direction, stagnant without significant progress, or regressing.

“In some jurisdictions, cannabis comes with real freedom. In others, it still comes with real consequences,” NORML Director of Development JM Pedini said in a press release. “This survey is about capturing that gap, not just what the laws say, but how people actually experience them.”

Pedini told Marijuana Moment that the organization will likely compile the results and release them a few days before 4/20.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Governor vetoes medical cannabis bill

Published

on

By











The veto pen is one of the most powerful tools in the Mississippi Legislature, and Governor Tate Reeves has used it throughout his tenure. This year, his vetoes have mostly targeted public health bills so far, with more to come.

There are three ways Reeves could handle the bills that passed both chambers. He can sign bills he supports and allow them to become law without his signature. He can also block legislation he disagrees with by vetoing a bill or part of it and deferring it to a future legislative session.

As of Wednesday, April 8, he has vetoed four bills, half as many as in the previous two sessions, but Reeves will continue to review the legislation and reject more proposals in the coming days.

Reeves vetoed two medical marijuana bills that passed the Legislature this session, dealing a fatal blow to bills that have already faced friendly chambers. One of the bills, the “Right to Try Medical Cannabis,” contained only one specific provision that Reeves disputed. The original intent of the bill, which Reeves praised, was to expand the opportunity to try medical marijuana to those with debilitating conditions that fall outside the scope of current law.

Read more at Clarion Ledger










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media